Clinical trial registry record

Elderly Cancer PatIents, Safety and qualiTy of Life Under immunOtheraPies

A registered PHASE4 study indexed because it matched monitored longevity research terms. Registry status: Terminated. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Terminated.
Evidence
Registered phase 4 study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated January 22, 2026.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT03673332
Last registry update
January 22, 2026
Status
Terminated
Phase
Phase 4
Sponsor
Institut Paoli-Calmettes
Enrollment
40
Countries
France
Match confidence
80%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered PHASE4 study indexed because it matched monitored longevity research terms. Registry status: Terminated. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase 4
Study design
NA · SINGLE GROUP · TREATMENT · NONE
Evidence population
Human clinical study registration
Participants
40
Population
ALL · 70 Years
Duration
2019-10-16 to 2024-10-29
Intervention
immune-checkpoint inhibitors therapies
Comparator
Not reported
Outcomes measured
Number of participants adverse events as assessed by CTCAE v5.0 — From treatment initiation to 18 weeks after treatment…; European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire (QLQ-C30) and Elderly Can…; geriatric data modifications under treatment — From inclusion until treatment discontinuation (up to 24 months); compare patients and clinician symptoms reporting — From treatment initiation to 18 weeks after treatment initiation.(u…; Progression-free survival — time from treatment beginning to radiological or clinical progression of the disease, or de…; Overall Survival — time from treatment beginning to death of any cause (up to 24 months); correlation between toxicity and efficacy — time from treatment beginning to radiological or clinical progression of th…; rate of grade 3 to 5 adverse events 18 weeks after treatment initiation — From treatment initiation to 18 weeks after t…
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase 4A trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 80% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Cancer and ageing · 80%Title contains controlled topic terminology. Title supplies ageing or longevity context.

Automated source check 100% · update recency 85%. These figures help sort records; they are not medical ratings.

cancer and aging
Read the original source →Export JSON